Ray Dalio Zai Lab LTD Transaction History

Bridgewater Associates, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $203,791 - $319,541	-8,055 Reduced 5.64%	134,657 $3.73 Million
Q1 2023 May 12, 2023	SELL	$30.21 - $48.1 $10 Million - $16 Million	-332,300 Reduced 69.96%	142,712 $4.75 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $4.36 Million - $7.57 Million	-195,553 Reduced 29.16%	475,012 $14.6 Million
Q3 2022 Nov 10, 2022	BUY	$34.2 - $51.69 $1.14 Million - $1.73 Million	33,384 Added 5.24%	670,565 $22.9 Million
Q2 2022 Aug 11, 2022	BUY	$23.14 - $49.68 $6.55 Million - $14.1 Million	283,213 Added 80.01%	637,181 $22.1 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $4.38 Million - $10.2 Million	157,824 Added 80.46%	353,968 $15.6 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $2.07 Million - $3.96 Million	37,656 Added 23.76%	196,144 $12.3 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $6.71 Million - $11.4 Million	63,908 Added 67.57%	158,488 $16.7 Million
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $375,079 - $539,640	-2,998 Reduced 3.07%	94,580 $16.7 Million
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $4.37 Million - $6.64 Million	-34,646 Reduced 26.2%	97,578 $13 Million
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $2.09 Million - $3.45 Million	25,455 Added 23.84%	132,224 $17.9 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $3.15 Million - $3.84 Million	42,932 Added 67.25%	106,769 $8.88 Million
Q2 2020 Aug 12, 2020	BUY	$48.82 - $82.53 $3.12 Million - $5.27 Million	63,837 New	63,837 $5.24 Million

122

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.67B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.